Limitations, agreements, and source contact

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck · Source last updated 2020-05-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Study funding unavailable therefore study terminated early. Both patients did not complete treatment per protocol and were not evaluable.

point Of Contact

email

Panayiotis.Savvides@uhhospitals.org

organization

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

phone

216-844-5946

title

Panayiotis Savvides, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice